BIO’s Industry Analysis Team presents Emerging Therapeutic Company trends across five core areas of investment and deal-making: venture capital, initial public offerings (IPOs), follow-on public ...

As the largest global non-profit biotechnology trade association representing startups to Fortune 500 companies, BIO is proud to host a portfolio of partnering conferences that not only unite and ...

Interested in Learning More About BIO Events? Through education, collaboration and advocacy, BIO strives to drive a bio-revolution that cures patients, protects our climate, and nourishes humanity.